These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 8088093)

  • 1. Evolving role of cardiopulmonary exercise testing in cardiovascular disease.
    Tjahja IE; Reddy HK; Janicki JS; Weber KT
    Clin Chest Med; 1994 Jun; 15(2):271-85. PubMed ID: 8088093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiopulmonary exercise testing: a review of methods and applications in surgical patients.
    Ridgway ZA; Howell SJ
    Eur J Anaesthesiol; 2010 Oct; 27(10):858-65. PubMed ID: 20689441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The integrative cardiorespiratory exercise test: 2. Response to maximal exercise in heart and lung diseases].
    Oren A; Ben-Dov I
    Harefuah; 1989 Jun; 116(11):561-9. PubMed ID: 2792931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular testing in Fabry disease: exercise capacity reduction, chronotropic incompetence and improved anaerobic threshold after enzyme replacement.
    Lobo T; Morgan J; Bjorksten A; Nicholls K; Grigg L; Centra E; Becker G
    Intern Med J; 2008 Jun; 38(6):407-14. PubMed ID: 18613897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of sildenafil on cardiopulmonary responses during stress.
    Stanopoulos I; Hatzichristou D; Tryfon S; Tzortzis V; Apostolidis A; Argyropoulou P
    J Urol; 2003 Apr; 169(4):1417-21. PubMed ID: 12629375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applications of cardiopulmonary exercise testing in the management of cardiovascular and pulmonary disease.
    Myers J
    Int J Sports Med; 2005 Feb; 26 Suppl 1():S49-55. PubMed ID: 15702456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of low altitude at the Dead Sea on exercise capacity and cardiopulmonary response to exercise in cystic fibrosis patients with moderate to severe lung disease.
    Falk B; Nini A; Zigel L; Yahav Y; Aviram M; Rivlin J; Bentur L; Avital A; Dotan R; Blau H
    Pediatr Pulmonol; 2006 Mar; 41(3):234-41. PubMed ID: 16429430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cardiopulmonary exercise test is safe and reliable in elderly patients with chronic heart failure.
    Scardovi AB; Coletta C; De Maria R; Perna S; Aspromonte N; Feola M; Rosso G; Greggi M; Ceci V
    J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):608-12. PubMed ID: 17667032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of cardiac resynchronisation therapy on adaptation of circulatory and respiratory systems to exercise assessed by cardiopulmonary exercise test in patients with chronic heart failure.
    Chwyczko T; Sterliński M; Maciag A; Firek B; Labecka A; Jankowska A; Kośmicki M; Kowalik I; Malczewska B; Szwed H
    Kardiol Pol; 2008 Apr; 66(4):406-12; discussion 413-4. PubMed ID: 18473269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiopulmonary exercise testing: current applications.
    Stringer WW
    Expert Rev Respir Med; 2010 Apr; 4(2):179-88. PubMed ID: 20406084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of heart rate during exercise for response to cardiac resynchronization therapy.
    Maass AH; Buck S; Nieuwland W; Brügemann J; van Veldhuisen DJ; Van Gelder IC
    J Cardiovasc Electrophysiol; 2009 Jul; 20(7):773-80. PubMed ID: 19207785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between CD34+ and exercise capacity, functional class, quality of life and norepinephrine in heart failure patients.
    Carvalho VO; Ruiz MA; Bocchi EA; Carvalho VO; Guimarães GV
    Cardiol J; 2009; 16(5):426-31. PubMed ID: 19753521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cardiopulmonary exercise tests -- proposals for standardization and interpretation].
    Breuer HW
    Pneumologie; 2004 Aug; 58(8):553-65. PubMed ID: 15293169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiopulmonary exercise testing].
    Ilarraza-Lomelí H
    Arch Cardiol Mex; 2012; 82(2):160-9. PubMed ID: 22735657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exercise Testing: Who, When, and Why?
    Nelson N; Asplund CA
    PM R; 2016 Mar; 8(3 Suppl):S16-23. PubMed ID: 26972264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An integrated approach to the interpretation of cardiopulmonary exercise testing.
    Weisman IM; Zeballos RJ
    Clin Chest Med; 1994 Jun; 15(2):421-45. PubMed ID: 8088102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardiopulmonary exercise testing].
    Ulubay G; Oner Eyüboğlu F
    Tuberk Toraks; 2006; 54(1):90-8. PubMed ID: 16615025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the 6-minute walk test with established parameters for assessment of cardiopulmonary capacity in adults with complex congenital cardiac disease.
    Niedeggen A; Skobel E; Haager P; Lepper W; Mühler E; Franke A
    Cardiol Young; 2005 Aug; 15(4):385-90. PubMed ID: 16014186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Objective assessment of subjective symptom in chronic heart failure].
    Matsui S; Tamura N
    Rinsho Byori; 1998 Jan; 46(1):33-42. PubMed ID: 9492536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of supervised cardiovascular training program on exercise tolerance, aerobic capacity, and quality of life in patients with systemic lupus erythematosus.
    Carvalho MR; Sato EI; Tebexreni AS; Heidecher RT; Schenkman S; Neto TL
    Arthritis Rheum; 2005 Dec; 53(6):838-44. PubMed ID: 16342102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.